Clinical Trial Update: Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38 [Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy of dinoprostone (Propess) in women with premature rupture of membranes or gestational age under 38 weeks (Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induction of Labor

Drugs mentioned

• Propess (dinoprostone)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Induction of Labor | Phase 2 | Status: COMPLETED